Whitehawk Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Whitehawk Therapeutics, Inc. (WHWK) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-63.69-65.77-60.51-110.10-3.48
Depreciation & Amortization0.190.17-1.060.110.01
Stock Based Compensation10.8411.959.642.110.14
Change in Working Capital-6.05-3.40-1.5312.37-10.51
Change in Accounts Receivable-0.42-3.63-1.8614.15-13.86
Change in Inventory1.12-3.27-1.860.000.00
Change in Accounts Payable-9.77-0.133.228.291.08
Change in Other Working Capital3.023.620.38-10.192.28
Other Operating Activities0.460.5213.4675.381.14
Net Cash from Operating Activities-59.55-59.66-49.64-22.43-12.70
Investing Activities
Capital Expenditures-1.65-3.970.440.050.00
Acquisitions0.000.000.0025.200.00
Purchases of Investments26.8687.18-145.190.000.00
Sales/Maturities of Investments0.00151.62-132.4425.200.00
Other Investing Activities26.860.000.0025.200.00
Net Cash from Investing Activities25.2083.21-132.8925.150.00
Financing Activities
Common Stock Issued0.150.490.32155.000.00
Dividends Paid0.000.000.004.410.00
Other Financing Activities-0.02-0.16-0.66-9.620.00
Net Cash from Financing Activities0.130.3372.62141.801.19
Summary
Net Change in Cash-34.2223.87-109.91144.52-11.51
Cash at Beginning of Period62.9539.08148.994.460.00
Cash at End of Period28.7362.9539.08148.980.00
Free Cash Flow-61.20-63.64-50.08-22.48-12.70
Supplemental Disclosures
Interest Paid0.210.230.230.020.00